火巖控股(01909.HK)可能根據一般授權配售新股份
格隆匯6月18日丨火巖控股(01909.HK)公吿,公司正與潛在配售代理初步討論有關可能配售公司新股份的事宜。集團預期可能配售(倘作實)將為集團業務提供支持,包括(i)於東南亞各地設立研發團隊併發行遊戲;(ii)提供足夠資金以便集團於適當時侯收購或投資遊戲及其他與集團業務能產生互動的互聯網項目;及(iii)補充集團的營運資金。
就可能配售而言,公司目前擬根據於2025年5月30日舉行的公司股東周年大會上通過的普通決議案授予董事的一般授權,向獨立第三方配發及發行公司的新股份。根據上述一般授權配發及發行的股份最高數目為38,400,000股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.